Differential regulation of human T cell cytokine patterns and IgE and lgG4 responses by conformational antigen variants

European Journal of Immunology

Volumn 28, Issue 3, 1998, Pages 914-925

  Akdis, Cezmi A ^a   Blesken, Thorsten ^a   Wymann, Daniel ^a   Akdis, Mübeccel ^a   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Antigen conformation; Antigen presentation; IgE regulation; Recombinant allergen; Th1; Th2

Indexed keywords

ALLERGEN; BEE VENOM; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MEMBRANE PHOSPHOLIPID; PHOSPHOLIPASE A2; T LYMPHOCYTE ANTIGEN;

ALLERGY; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; ARTICLE; B LYMPHOCYTE; BEE STING; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MONONUCLEAR CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BEE VENOMS; CD40 LIGAND; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MONOCYTES; PHOSPHOLIPASES A; PROTEIN CONFORMATION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 0031881193     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C     Document Type: Article

References (52)

1. Lanzavecchia, A., Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 1996. 8: 348-354.
2. Nelson, C. A., Petzold, S. J. and Unanue, E. R., Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 1994. 371: 250-252.
3. Valitutti, S., Muller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T cell receptors by a few peptide MHC complexes. Nature 1995. 375: 145-151.
4. + T cells. I. Influence of antigen concentration and antigen presenting cell type. J. Immunol. 1992. 149: 3468-3476.
5. + T cells from allergic individuals is modulated by antigen concentration and antigen presenting cell type. J. Exp. Med. 1995. 181: 1081-1089.
6. Paul, W. E. and Seder, R. A., Lymphocyte responses and cytokines. Cell 1994. 76: 241-251.
7. Mosmann, T. R. and Sad, S., The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996. 17: 142-146.
8. Romagnani, S., Human Th1 and Th2 subsets: doubt no more. Immunol. Today 1991. 12: 256-257.
9. Sallusto, F., Mackay, C. R. and Lanzavecchia, A., Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997. 277: 2005-2007.
10. Trinchieri, G., Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995. 13: 251-263.
11. + T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 1993. 90: 10188-10192.
12. Scott, P., IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 1991. 147: 3149-3155.
13. + T lymphocytes. J. Immunol. 1995. 155: 111-117.
14. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M. C., Bluethmann, H. and Köhler, G., Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993. 362: 245-248.
15. Finkelman, F. D., Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease. J. Exp. Med. 1995. 182: 279-282.
16. Jabara, H. H. and Vercelli, D., Engagement of CD14 on monocytes inhibits the synthesis of human Igs including IgE. J. Immunol. 1994. 153: 972-978.
17. Matthes, T., Werner-Favre, C., Tang, H., Zhang, X., Kindler, V. and Zubler, H. R., Cytokine mRNA expression during an in vitro response of human B lymphocytes: Kinetics of B cell tumor necrosis factor α, interleukin (IL)6, IL-10, and Transforming Growth Factor β 1 mRNAs. J. Exp. Med. 1993. 178: 521-528.
18. Pistoia, V., Production of cytokines by human B cells in health and disease. Immunol. Today 1997. 18: 343-350.
19. Aalberse, R. C., Van Milligen, F., Tan, K. Y. and Stapel, S. O., Allergen-specific IgG4 in atopic disease. Allergy 1993. 48: 559-569.
20. De Vries, J. E., Carballido, J. M., Sornasse, T. and Yssel, H., Antagonizing the differentiation and functions of human T helper type 2 cells. Curr. Opin. Immunol. 1995. 7: 771-778.
21. Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N. J., Menon, S., Zurawski, G., De Waal Malefyt, R. and De Vries, J. E., Interleukin-13 induces interleukin-4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 1993. 90: 3730-3734.
22. 2. Proc. Natl. Acad. Sci. USA 1988. 85: 6880-6884.
23. 2 in vitro. J. Allergy Clin. Immunol. 1994. 93: 758-767.
24. 2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J. Allergy Clin. Immunol. 1997. 99: 345-353.
25. Kagey-Sabotka, A., Franklin, R. M., Adkinson Jr., N. F., Valentine, M., Bauer, H. and Lichtenstein, L. M., Allergy to insect sting II. Phospholipase A: the major allergen in honey BV. J. Allergy Clin. Immunol. 1976. 57: 29-40.
26. Müller, U. R., Dudler, T., Schneider, T., Crameri, R., Fischer, H., Skrbic, D., Maibach, R., Blaser, K. and Suter, M., Type 1 skin reactivity to native and recombinant phospholipase A2 from honey BV is similar. J. Allergy Clin. Immunol. 1995. 96: 395-402.
27. 2 from honey BV glands. Eur. J. Biochem. 1989. 184: 249-254.
28. 2 in a complex with a transition-state analogue. Science 1990. 250: 1563-1566.
29. 2. Biochim. Biophys. Acta 1992. 1165: 201-210.
30. 2. J. Immunol. 1995. 155: 2605-2613.
31. 2. J. Allergy Clin. Immunol. 1994. 94: 61-69.
32. 2. J. Immunol. 1993. 150: 3582-3591.
33. 2 in BV immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 1996. 98: 1676-1683.
34. Yang, X., Gieni, R. S., Mosmann, T. R. and HayGlass, K. T., Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 1993. 178: 349-353.
35. Vailes, L. D., Ying, L., Bao, Y., DeGroot, H., Aalberse, R. C. and Chapman, M. D., Fine specificity of B-cell epitopes on Felis domesticus allergen I (Fel d I): Effect of reduction and alkylation and deglycosylation on Fel d I structure and antibody binding. J. Allergy Clin. Immunol. 1994. 93: 22-33.
36. + T cells. J. Exp. Med. 1993. 178: 1655-1663.
37. Nadler, S. G., Rankin, B. M., Moran-Davis, P., Cleaveland, J. S. and Kiener, P. A., Effect of interferon-γ on antigen processing in human monocytes. Eur. J. Immunol. 1994. 24: 3124-3130.
38. Carballido, J. M., Faith, A., Carballido-Perrig, N. and Blaser, K., The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific Th cells. Eur. J. Immunol. 1997. 27: 515-521.
39. Gajewski, T. F., Pinnas, M., Wong, T. and Fitch, F. W., Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol. 1991. 146: 1750-1758.
40. Evavold, B. D. and Allen, P. M., Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991. 252: 1308-1310.
41. Pfeiffer, C., Murray, J., Madri, J. and Bottomly, K., Selective activation of Th1-and Th2-like cells in vivo-response to human collagen IV. Immunol. Rev. 1991. 123: 65-84.
42. 2. J. Immunol. 1993. 151: 5675-5684.
43. 2 has the same potency to release histamine from basophils in patients with Hymenoptera allergy. J. Allergy Clin. Immunol. 1995. 95: 1229-1235.
44. Santamaria, L. F., Bheekha, R., van Reijsen, F. C., Perez Soler, M. T., Suter, M., Bruijnzedel-Komen, C. A. F. M. and Mudde, G. C., Antigen focusing by specific monomeric immunoglobulin E bound CD23 on Epstein-Barr virus transformed B cells. Hum. Immunol. 1993. 37: 23-30.
45. Müller, U., Epidemiology of insect sting allergy. In: Epidemiology of clinical allergy. Burr, M. (Ed.), Monogr. Allergy. Karger, Basel 1993. 31: 131-146.
46. Müller, U., Rabson, A., Bischof, M., Lomnitzer, R., Dreborg, S. and Lanner, A., A double blind study comparing monomethoxy polyethylene glycol modified honey BV and unmodified honey BV for immunotherapy. J. Allergy Clin. Immunol. 1987. 80: 252-261.
47. Müller, U., Morris, T., Bischof, M., Friedli, H. and Skvaril, F., Combined active and passive immunotherapy in honey bee-sting allergy. J. Allergy Clin. Immunol. 1986. 78: 115-122.
48. Müller, U., M. Fricker, M., Akdis, C. A., Carballido, J. and Blaser, K., Successful immunotherapy with T-cell epitopes of BV phospholipase A2 (PLA) in patients with BV (BV) allergy. J. Allergy Clin. Immunol. 1996. 97: 426.
49. Mueller, H. L., Diagnosis and treatment of insect sensitivity. J. Asthma Res. 1966. 3: 331-333.
50. Lane, P., Brocker, T., Hubele, S., Padovan, E., Lanzavecchia, A. and Mc Connell, F. F., Soluble CD40 ligand can replace the normal Tcell derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 1993. 177: 1209-1213.
51. Alkan, S. S., Akdis, C. A. and Towbin, H., Chemiluminescent and enzyme-linked immuno assays for sensitive detection of human IFN-γ. J. Immunoassay 1994. 15: 217-238.
52. Gillis, S., Ferm, M. M., Ou, W. and Smith, K. A., T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 1978. 120: 2027-2032.